{"id":"NCT03386032","sponsor":"Procter and Gamble","briefTitle":"8-Week Atopic Dermatitis (AD) Treatment Study","officialTitle":"8-Week Atopic Dermatitis (AD) Treatment Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-27","primaryCompletion":"2018-08-18","completion":"2018-08-18","firstPosted":"2017-12-29","resultsPosted":"2020-12-17","lastUpdate":"2020-12-17"},"enrollment":65,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis Eczema"],"interventions":[{"type":"DRUG","name":"Investigational OTC Cream","otherNames":[]},{"type":"DRUG","name":"0.05% Desonide","otherNames":["Desowen"]},{"type":"OTHER","name":"Placebo Cream","otherNames":["Vehicle"]}],"arms":[{"label":"Investigational OTC Cream","type":"EXPERIMENTAL"},{"label":"Placebo Cream","type":"SHAM_COMPARATOR"},{"label":"0.05% Desonide Cream","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).","primaryOutcome":{"measure":"Severity Scoring of Atopic Dermatitis (SCORAD) Amongst Subjects With Moderate Atopic Dermatitis","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"Investigational OTC Cream","deltaMin":-12.2,"sd":3.99},{"arm":"Placebo Cream","deltaMin":9.3,"sd":6.51},{"arm":"0.05% Desonide Cream","deltaMin":-17.5,"sd":8.29}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"<0.05"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":20},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":36},"commonTop":["Atopic /Other"]}}